1. Home
  2. ICUCW vs PTON Comparison

ICUCW vs PTON Comparison

Compare ICUCW & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • PTON
  • Stock Information
  • Founded
  • ICUCW N/A
  • PTON 2012
  • Country
  • ICUCW United States
  • PTON United States
  • Employees
  • ICUCW 12
  • PTON N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • PTON Recreational Games/Products/Toys
  • Sector
  • ICUCW Health Care
  • PTON Consumer Discretionary
  • Exchange
  • ICUCW Nasdaq
  • PTON Nasdaq
  • Market Cap
  • ICUCW N/A
  • PTON N/A
  • IPO Year
  • ICUCW 2021
  • PTON 2019
  • Fundamental
  • Price
  • ICUCW $0.04
  • PTON $6.27
  • Analyst Decision
  • ICUCW
  • PTON Hold
  • Analyst Count
  • ICUCW 0
  • PTON 20
  • Target Price
  • ICUCW N/A
  • PTON $8.03
  • AVG Volume (30 Days)
  • ICUCW N/A
  • PTON 12.0M
  • Earning Date
  • ICUCW N/A
  • PTON 05-05-2025
  • Dividend Yield
  • ICUCW N/A
  • PTON N/A
  • EPS Growth
  • ICUCW N/A
  • PTON N/A
  • EPS
  • ICUCW N/A
  • PTON N/A
  • Revenue
  • ICUCW N/A
  • PTON $2,621,100,000.00
  • Revenue This Year
  • ICUCW N/A
  • PTON N/A
  • Revenue Next Year
  • ICUCW N/A
  • PTON N/A
  • P/E Ratio
  • ICUCW N/A
  • PTON N/A
  • Revenue Growth
  • ICUCW N/A
  • PTON N/A
  • 52 Week Low
  • ICUCW N/A
  • PTON $2.70
  • 52 Week High
  • ICUCW N/A
  • PTON $10.90
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • PTON 52.41
  • Support Level
  • ICUCW N/A
  • PTON $5.17
  • Resistance Level
  • ICUCW N/A
  • PTON $6.37
  • Average True Range (ATR)
  • ICUCW 0.00
  • PTON 0.46
  • MACD
  • ICUCW 0.00
  • PTON 0.14
  • Stochastic Oscillator
  • ICUCW 0.00
  • PTON 91.38

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: